Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Hope Bancorp
HOPE
$1.79B
| $705K | ﹤0.01% |
61,404
+3
| +0% | +$34 |
|
1827
City Holding Co
CHCO
$2.04B
| $705K | ﹤0.01% |
6,774
| – | – |
|
1828
Erie Indemnity
ERIE
$12.2B
| $704K | ﹤0.01% |
1,753
| – | – |
|
1829
AtriCure
ATRC
$2.04B
| $703K | ﹤0.01% |
23,121
| – | – |
|
1830
Cracker Barrel
CBRL
$1.28B
| $703K | ﹤0.01% |
9,672
+1
| +0% | +$72 |
|
1831
Cohu
COHU
$2.19B
| $703K | ﹤0.01% |
21,077
| – | – |
|
1832
Coursera
COUR
$1.51B
| $702K | ﹤0.01% |
50,115
-26
| -0.1% | -$441 |
|
|
BBBY
1833
Bed Bath & Beyond
BBBY
$472M
| $702K | ﹤0.01% |
21,530
-1
| -0% | -$26 |
|
1834
Telephone and Data Systems
TDS
$3.82B
| $700K | ﹤0.01% |
43,725
+5
| +0% | +$85 |
|
1835
Fastly Inc
FSLY
$3.37B
| $697K | ﹤0.01% |
53,780
+12
| +0% | +$203 |
|
1836
Jack in the Box
JACK
$312M
| $697K | ﹤0.01% |
10,185
-2
| -0% | -$151 |
|
1837
Helix Energy Solutions
HLX
$1.36B
| $692K | ﹤0.01% |
63,883
+4
| +0% | +$39 |
|
1838
Zillow
Z
$7.71B
| $690K | ﹤0.01% |
14,157
+1
| +0% | +$54 |
|
1839
NETSCOUT
NTCT
$2.91B
| $690K | ﹤0.01% |
31,606
+1
| +0% | +$22 |
|
1840
Arhaus
ARHS
$1.04B
| $688K | ﹤0.01% |
44,774
+29,231
| +188% | +$376K |
|
1841
Manhattan Associates
MANH
$11.1B
| $687K | ﹤0.01% |
2,746
+432
| +19% | +$103K |
|
1842
TTM Technologies
TTMI
$12B
| $686K | ﹤0.01% |
43,874
+2
| +0% | +$30 |
|
1843
Ginkgo Bioworks
DNA
$528M
| $685K | ﹤0.01% |
14,705
+7
| +0% | +$362 |
|
1844
UiPath
PATH
$6.41B
| $684K | ﹤0.01% |
30,169
+2
| +0% | +$47 |
|
1845
Pan American Silver
PAAS
$18.6B
| $682K | ﹤0.01% |
45,279
+24,847
| +122% | +$343K |
|
1846
Global Net Lease
GNL
$1.86B
| $682K | ﹤0.01% |
87,798
+5
| +0% | +$41 |
|
1847
Unity
U
$14.6B
| $681K | ﹤0.01% |
25,533
-10
| -0% | -$314 |
|
1848
Veracyte
VCYT
$4.77B
| $679K | ﹤0.01% |
30,699
+3
| +0% | +$73 |
|
1849
Caleres
CAL
$437M
| $677K | ﹤0.01% |
16,509
+2
| +0% | +$70 |
|
1850
Alaska Air
ALK
$5.27B
| $677K | ﹤0.01% |
15,749
+1
| +0% | +$37 |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.